Reuters logo
BRIEF-KemPharm says completed meeting with FDA on KP415
November 16, 2017 / 12:44 PM / a month ago

BRIEF-KemPharm says completed meeting with FDA on KP415

Nov 16 (Reuters) - KemPharm Inc-

* KemPharm completes successful end-of-Phase 2 meeting on KP415 with FDA

* KemPharm - held meeting to discuss status of proposed clinical, non-clinical,abuse liability studies, among others for submission of NDA for KP415​

* KemPharm - ‍meeting with FDA helped confirm remain on schedule in KP415 development program, including work required to complete other standard protocols​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below